Festivals Highlight North Carolina Happenings All Year Long
We’d say you could call it “festival season,” but that wouldn’t be quite right. That’s because in North Carolina, we’re fortunate to have an assortment of fun and funky festivals year-round. From food to music to gardens to boats, and so much more, there’s a festival in North Carolina for all ages, tastes, and interests this year. We’ve selected just a few of our favorites, but we want to hear from you if there are any you think we missed. Be sure to leave us a note in the comments here on our blog or on Facebook to let us know!
Phrma Blames the Hostage Negotiator for Killing the Hostage
I don’t want to live in a world with hostage negotiators. Don’t get me wrong. I’m deeply thankful that there are people who are willing, able and skilled at doing such a difficult job. But I wish we lived in a world where there were no evil people who were willing to take hostages.
Who is Pharma Going to Blame When PBMs are Gone and Drug Prices are Still Crazy?
The pharmaceutical industry, who make our drugs (good) and then set outlandish prices for them (bad), has developed a unique logic to blame PBMs (Pharmacy Benefit Managers - the people whose job it is to negotiate lower prices for consumers) for the higher price of drugs.
Hospital Chargemasters Leading to Confused Patients, Questions About Costs
A new federal law praised for what some considered a giant leap toward increased healthcare transparency may be making an already-confusing experience even more confusing. The rule effective Jan. 1 requires hospitals to publicize prices online for any services they offer. Unfortunately for patients, early reports on the process have not been favorable.
Generic Insulin Could Lower Costs, but Red Tape and Prescribing Habits Won’t Make It Easy
Imagine you spend years fine-tuning formulas and undergoing tests, trials, and experiments, before finally developing a potentially life-saving drug. And then two of your neighbors do the same. Over the next century or so, the three of you control the overwhelming majority of the market for that drug, raising prices as you wish and leaving little room for competition or a generic alternative.
Big Pharma Balks at Lowering Own Prices in Response to Rising Drug Costs
Leadership from seven different drug makers appeared before the Senate Finance Committee late last month , to provide their recommendations for solving the crisis surrounding drug costs. The executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, and Sanofi presented an assortment of ideas that were heavy on finger-pointing and light on actionable solutions.